IRIS Accounts Production v25.1.4.42 06721648 Board of Directors 1.11.23 31.10.24 31.10.24 0 0 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh067216482023-10-31067216482024-10-31067216482023-11-012024-10-31067216482022-10-31067216482022-11-012023-10-31067216482023-10-3106721648ns15:EnglandWales2023-11-012024-10-3106721648ns14:PoundSterling2023-11-012024-10-3106721648ns10:Director12023-11-012024-10-3106721648ns10:PrivateLimitedCompanyLtd2023-11-012024-10-3106721648ns10:SmallEntities2023-11-012024-10-3106721648ns10:AuditExempt-NoAccountantsReport2023-11-012024-10-3106721648ns10:SmallCompaniesRegimeForDirectorsReport2023-11-012024-10-3106721648ns10:SmallCompaniesRegimeForAccounts2023-11-012024-10-3106721648ns10:FullAccounts2023-11-012024-10-3106721648ns10:OrdinaryShareClass12023-11-012024-10-3106721648ns10:Director22023-11-012024-10-3106721648ns10:CompanySecretary12023-11-012024-10-3106721648ns10:RegisteredOffice2023-11-012024-10-3106721648ns5:CurrentFinancialInstruments2024-10-3106721648ns5:CurrentFinancialInstruments2023-10-3106721648ns5:Non-currentFinancialInstruments2024-10-3106721648ns5:Non-currentFinancialInstruments2023-10-3106721648ns5:ShareCapital2024-10-3106721648ns5:ShareCapital2023-10-3106721648ns5:RetainedEarningsAccumulatedLosses2024-10-3106721648ns5:RetainedEarningsAccumulatedLosses2023-10-3106721648ns5:LandBuildingsns5:OwnedOrFreeholdAssets2023-11-012024-10-3106721648ns5:LandBuildings2023-10-3106721648ns5:ComputerEquipment2023-10-3106721648ns5:LandBuildings2023-11-012024-10-3106721648ns5:ComputerEquipment2023-11-012024-10-3106721648ns5:LandBuildings2024-10-3106721648ns5:ComputerEquipment2024-10-3106721648ns5:LandBuildings2023-10-3106721648ns5:ComputerEquipment2023-10-3106721648ns5:WithinOneYearns5:CurrentFinancialInstruments2024-10-3106721648ns5:WithinOneYearns5:CurrentFinancialInstruments2023-10-3106721648ns10:OrdinaryShareClass12024-10-3106721648ns5:RetainedEarningsAccumulatedLosses2023-10-3106721648ns5:RetainedEarningsAccumulatedLosses2023-11-012024-10-31
REGISTERED NUMBER: 06721648 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 OCTOBER 2024

FOR

INNOVATE HEALTHCARE LIMITED

INNOVATE HEALTHCARE LIMITED (REGISTERED NUMBER: 06721648)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


INNOVATE HEALTHCARE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 OCTOBER 2024







DIRECTORS: Dr B Kohli
Ms S Paul





SECRETARY: Ms S Paul





REGISTERED OFFICE: 114-116 Goodmayes Road
Ilford
Essex
IG3 9UZ





REGISTERED NUMBER: 06721648 (England and Wales)





ACCOUNTANTS: Ashfords Partnership LLP
114 - 116 Goodmayes Road
Ilford
Essex
IG3 9UZ

INNOVATE HEALTHCARE LIMITED (REGISTERED NUMBER: 06721648)

BALANCE SHEET
31 OCTOBER 2024

31.10.24 31.10.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 461,139 471,782

CURRENT ASSETS
Debtors 5 1,407,577 589,266
Cash at bank and in hand 20,026 142,131
1,427,603 731,397
CREDITORS
Amounts falling due within one year 6 715,042 43,999
NET CURRENT ASSETS 712,561 687,398
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,173,700

1,159,180

CREDITORS
Amounts falling due after more than one year 7 602,200 602,200
NET ASSETS 571,500 556,980

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 9 571,400 556,880
SHAREHOLDERS' FUNDS 571,500 556,980

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

INNOVATE HEALTHCARE LIMITED (REGISTERED NUMBER: 06721648)

BALANCE SHEET - continued
31 OCTOBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17 July 2025 and were signed on its behalf by:





Dr B Kohli - Director


INNOVATE HEALTHCARE LIMITED (REGISTERED NUMBER: 06721648)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024


1. STATUTORY INFORMATION

Innovate Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - 2% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

INNOVATE HEALTHCARE LIMITED (REGISTERED NUMBER: 06721648)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2024


4. TANGIBLE FIXED ASSETS
Freehold Computer
property equipment Totals
£    £    £   
COST
At 1 November 2023 586,065 - 586,065
Additions - 1,438 1,438
At 31 October 2024 586,065 1,438 587,503
DEPRECIATION
At 1 November 2023 114,283 - 114,283
Charge for year 11,721 360 12,081
At 31 October 2024 126,004 360 126,364
NET BOOK VALUE
At 31 October 2024 460,061 1,078 461,139
At 31 October 2023 471,782 - 471,782

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.24 31.10.23
£    £   
Amounts owed by associates 1,401,100 581,100
Other debtors 6,477 8,166
1,407,577 589,266

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.24 31.10.23
£    £   
Amounts owed to associates 600,000 -
Taxation and social security 7,796 8,281
Other creditors 107,246 35,718
715,042 43,999

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
31.10.24 31.10.23
£    £   
Bank loans 602,200 602,200

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 602,200 602,200

INNOVATE HEALTHCARE LIMITED (REGISTERED NUMBER: 06721648)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2024


8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.10.24 31.10.23
value: £    £   
100 Ordinary £1 100 100

9. RESERVES
Retained
earnings
£   

At 1 November 2023 556,880
Profit for the year 14,520
At 31 October 2024 571,400

10. ULTIMATE CONTROLLING PARTY

During the year ended 31st October 2024, the company was jointly controlled by the director's by virtue of their shareholding in the company.